RankingsPricing
  1. JP-listed companies
  2. ReproCELL Incorporated
  3. Financials
  4. Capital expenditures

ReproCELL IncorporatedJP:4978

Market cap
¥14.1B
P/E ratio
-188.6x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCapital expenditures (Million JPY)YoY (%)
Mar 31, 2025-87-49.43%
Mar 31, 2024-171+14.00%
Mar 31, 2023-150+246.48%
Mar 31, 2022-43-27.48%
Mar 31, 2021-60-50.17%
Mar 31, 2020-120+30.65%
Mar 31, 2019-92+112.05%
Mar 31, 2018-43-33.86%
Mar 31, 2017-66+125.02%
Mar 31, 2016-29-8.46%
Mar 31, 2015-32

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)